Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov 6:8:153.
doi: 10.1186/1471-2334-8-153.

Ability of online drug databases to assist in clinical decision-making with infectious disease therapies

Hyla H Polen  1 , Antonia Zapantis, Kevin A Clauson, Jennifer Jebrock, Mark Paris
Affiliations

Ability of online drug databases to assist in clinical decision-making with infectious disease therapies

Hyla H Polen et al. BMC Infect Dis. .

Abstract

Background: Infectious disease (ID) is a dynamic field with new guidelines being adopted at a rapid rate. Clinical decision support tools (CDSTs) have proven beneficial in selecting treatment options to improve outcomes. However, there is a dearth of information on the abilities of CDSTs, such as drug information databases. This study evaluated online drug information databases when answering infectious disease-specific queries.

Methods: Eight subscription drug information databases: American Hospital Formulary Service Drug Information (AHFS), Clinical Pharmacology (CP), Epocrates Online Premium (EOP), Facts & Comparisons 4.0 Online (FC), Lexi-Comp (LC), Lexi-Comp with AHFS (LC-AHFS), Micromedex (MM), and PEPID PDC (PPDC) and six freely accessible: DailyMed (DM), DIOne (DIO), Epocrates Online Free (EOF), Internet Drug Index (IDI), Johns Hopkins ABX Guide (JHAG), and Medscape Drug Reference (MDR) were evaluated for their scope (presence of an answer) and completeness (on a 3-point scale) in answering 147 infectious disease-specific questions. Questions were divided among five classifications: antibacterial, antiviral, antifungal, antiparasitic, and vaccination/immunization. Classifications were further divided into categories (e.g., dosage, administration, emerging resistance, synergy, and spectrum of activity). Databases were ranked based on scope and completeness scores. ANOVA and Chi-square were used to determine differences between individual databases and between subscription and free databases.

Results: Scope scores revealed three discrete tiers of database performance: Tier 1 (82-77%), Tier 2 (73-65%) and Tier 3 (56-41%) which were significantly different from each other (p < 0.05). The top tier performers: MM (82%), MDR (81%), LC-AHFS (81%), AHFS (78%), and CP (77%) answered significantly more questions compared to other databases (p < 0.05). Top databases for completeness were: MM (97%), DM (96%), IDI (95%), and MDR (95%). Subscription databases performed better than free databases in all categories (p = 0.03). Databases suffered from 37 erroneous answers for an overall error rate of 1.8%.

Conclusion: Drug information databases used in ID practice as CDSTs can be valuable resources. MM, MDR, LC-AHFS, AHFS, and CP were shown to be superior in their scope and completeness of information, and MM, AHFS, and MDR provided no erroneous answers. There is room for improvement in all evaluated databases.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scope comparison of drug information categories between subscription and free databases.
Figure 2
Figure 2
Completeness comparison of drug information categories between subscription and free databases.
See this image and copyright information in PMC

References

    1. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R, Ives J, Laird N, Laffel G, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995;274:35–43. doi: 10.1001/jama.274.1.35. - DOI - PubMed
    1. Kohn LT, Corrigan JM, Donaldson MS, Institute of Medicine . To err is human: building a safer health system. Washington, DC: National Academy Press; 2000. - PubMed
    1. Sintchenko V, Iredell JR, Gilbert GL. Comparative impact of guidelines, clinical data, and decision support on prescribing decisions: an interactive web experiment with simulated cases. J Am Med Inform Assoc. 2004;11:71–7. doi: 10.1197/jamia.M1166. - DOI - PMC - PubMed
    1. Leape LL, Berwick DM. Five years after To Err Is Human: what have we learned? JAMA. 2005;293:2384–90. doi: 10.1001/jama.293.19.2384. - DOI - PubMed
    1. Partin B. Preventing medication errors: an IOM Report. Nurse Pract. 2006;31:8. doi: 10.1097/00006205-200612000-00002. - DOI - PubMed

Substances